Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study

被引：0
|
作者：
Vermeire, S. [1 ]
Colombel, J. F. [2 ]
Rubin, D. T. [3 ]
Ghosh, S. [4 ]
Jain, A. [5 ]
Lawlor, G. [5 ]
Osterman, M. T. [5 ]
Wu, H. [5 ]
Canavan, J. B. [5 ]
Chiorean, M. V. [6 ]
机构：
[1] Univ Leuven, Chron Dis & Metab, Leuven, Belgium
[2] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY USA
[3] Univ Chicago Med, Gastroenterol, Inflammatory Bowel Dis Ctr, Chicago, IL USA
[4] Univ Birmingham Birmingham, Immunol & Immunotherapy, Birmingham, W Midlands, England
[5] Bristol Myers Squibb, Clin Res, Princeton, NJ USA
[6] Swedish Gastroenterol, Gastroenterol, Issaquah, WA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P715
引用
收藏
页码：844 / 845
页数：2
相关论文
共 33 条
  • [1] ACHIEVEMENT AND MAINTENANCE OF ENDOSCOPIC, HISTOLOGIC, AND COMBINED OUTCOMES AFTER EXTENDED INDUCTION IN WEEK 10 NONRESPONDERS OF OZANIMOD: 2-YEAR INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Chiorean, Michael V.
    Colombel, Jean Frederic
    Rubin, David T.
    Ghosh, Subrata
    Jain, Anjali
    Lawlor, Garrett
    Osterman, Mark T.
    Wu, Hsiuanlin
    Canavan, James B.
    Vermeire, Severine
    GASTROENTEROLOGY, 2023, 164 (06) : S1106 - S1107
  • [2] Endoscopic, histologic, and combined outcomes with reinitiation of ozanimod after temporary discontinuation: 2-year interim analysis of the True North open-label extension study
    Vermeire, S.
    Dignass, A.
    Colombel, J. F.
    Jain, A.
    Canavan, J. B.
    Wu, H.
    Lawlor, G.
    Osterman, M. T.
    Rubin, D. T.
    Regueiro, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I103 - I104
  • [3] ENDOSCOPIC, HISTOLOGIC, AND COMBINED OUTCOMES WITH REINITIATION OF OZANIMOD AFTER TEMPORARY DISCONTINUATION: 2-YEAR INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Regueiro, Miguel D.
    Dignass, Axel
    Colombel, Jean Frederic
    Jain, Anjali
    Canavan, James B.
    Wu, Hsiuanlin
    Lawlor, Garrett
    Osterman, Mark T.
    Rubin, David T.
    Vermeire, Severine
    GASTROENTEROLOGY, 2023, 164 (06) : S1105 - S1105
  • [4] Extended induction in the True North open-label extension study: clinical outcomes of ∼2 years of ozanimod treatment
    Vermeire, S.
    Colombel, J. F.
    Chiorean, M. V.
    Ghosh, S.
    Jain, A.
    Lawlor, G.
    Osterman, M. T.
    Wu, H.
    Canavan, J. B.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 903 - 904
  • [5] EXTENDED INDUCTION IN THE TRUE NORTH OPEN-LABEL EXTENSION STUDY: CLINICAL OUTCOMES OF ∼2 YEARS OF OZANIMOD TREATMENT
    Rubin, David T.
    Colombel, Jean Frederic
    Chiorean, Michael V.
    Ghosh, Subrata
    Jain, Anjali
    Lawlor, Garrett
    Osterman, Mark T.
    Wu, Hsiuanlin
    Canavan, James B.
    Vermeire, Severine
    GASTROENTEROLOGY, 2023, 164 (06) : S1102 - S1102
  • [6] Long-Term Clinical and Endoscopic Outcomes in True North Week 52 Clinical Remitters Over 3 Years of Treatment With Ozanimod: An Interim Analysis of the True North Open-Label Extension Study
    Afzali, Anita
    Rubin, David T.
    Abreu, Maria T.
    Chiorean, Michael V.
    Akukwe, Lucy
    Jain, Anjali
    Petersen, AnnKatrin
    Osterman, Mark T.
    Wu, Hsiuanlin
    Danese, Silvio
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S630 - S631
  • [7] Efficacy and Safety of 2 Years of Continuous Ozanimod Treatment: Interim Analysis of the True North Open-Label Extension Study
    Abreu, Maria T.
    Dulai, Parambir
    Dignass, Axel
    Savarino, Edoardo
    Hudesman, David
    Afzali, Anita
    Jairath, Vipul
    Osterman, Mark
    Akukwe, Lucy
    Liu, W. Jerry
    Memaj, Arteid
    Petersen, AnnKatrin
    Jain, Anjali
    Canavan, James B.
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S537 - S537
  • [8] Durability of Symptomatic and Clinical Outcomes in Ozanimod- Treated Patients by Endpoints of Increasing Objectivity at True North Week 52: Interim Analysis of the True North Open-Label Extension Study
    Abreu, Maria T.
    Panaccione, Remo
    Vermeire, Severine
    Rubin, David T.
    Mehra, Dimpy
    Wu, Hsiuanlin
    Osterman, Mark T.
    Ahmad, Harris A.
    Jain, Anjali
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S698 - S699
  • [9] Delayed Response to Ozanimod in Patients with Moderate vs Severe Endoscopic Disease: 4-Year Interim Analysis of the True North Open-Label Extension Study
    Wolf, Douglas C.
    Cross, Raymond K.
    Ritter, Timothy E.
    Stallmach, Andreas
    Hindryckx, Pieter
    Chang, Shannon
    Tharmarajah, Soba
    Wu, Hsiuanlin
    Osterman, Mark T.
    Jain, Anjali
    Irving, Peter M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1035 - S1035
  • [10] Efficacy and safety of 3 years of continuous ozanimod treatment: an interim analysis of the True North open-label extension study
    Danese, S.
    Abreu, M. T.
    Wolf, D. C.
    Canavan, J. B.
    Jain, A.
    Wu, H.
    Petersen, A.
    Charles, L.
    Panaccione, R.
    Afzali, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I101 - I102
1234